India covid-19 recommendations patient India

Pfizer’s Covid pill Paxlovid gets WHO's approval. All you need to know

Reading now: 654
www.livemint.com

Paxlovid over remdesivir, as well as over Merck's molnupiravir pill and monoclonal antibodies. Patients must start taking their Paxlovid pills within five days of the onset of symptoms -- the course then lasts five days.

WHO has also updated its recommendation on remdesivir, another antiviral medicine. Previously, WHO had suggested against its use in all COVID-19 patients regardless of disease severity, due to the totality of the evidence at that time showing little or no effect on mortality.

Following publication of new data from a clinical trial looking at the outcome of admission to hospital, WHO has updated its recommendation.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA